摘要
胰十二指肠切除术操作复杂,手术时间长且术后并发症发生率高,是普通外科领域难度较大的手术之一。随着微创外科技术的普及与进步,微创胰十二指肠切除术取得长足发展,其在可行性、安全性和肿瘤根治效果等方面不劣于甚至优于传统开腹手术。然而相关结论多来自单中心、回顾性研究,仍缺乏高质量证据支持。笔者基于近年来微创胰十二指肠切除术在适应证与禁忌证选择、可行性与安全性以及肿瘤根治效果与预后等方面的研究进展,同时结合临床经验分析其应用现状和潜在制约因素,以期为我国微创胰十二指肠切除术规范开展提供参考。
Pancreaticoduodenectomy is cumbersome and difficult to operate, with a long operative time and high risk of postoperative complications, thus it is one of the most complica-ted operations among general surgery. With the popularization and progress of minimally invasive techniques, minimally invasive pancreaticoduodenectomy (MIPD) has obtained a well developing. It has been confirmed that MIPD is noninferior or even superior to the traditional open pancreaticoduodenectomy in term of the feasibility, safety and effects of radical cure. How-ever, the relevant conclusions are mostly from single-center retrospective studies, without high-quality evidence support. The authors has reviewed the recent research progress of MIPD in the indications and contraindications, safety, feasibility and tumor curative effect, and illustrated the current status and prospects of MIPD with clinical experience and related literature, contributing to the standardization of MIPD in China.
作者
张太平
孙志伟
曹喆
冯梦宇
赵玉沛
Zhang Taiping;Sun Zhiwei;Cao Zhe;Feng Mengyu;Zhao Yupei(Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China)
出处
《中华消化外科杂志》
CAS
CSCD
北大核心
2019年第7期625-628,共4页
Chinese Journal of Digestive Surgery
基金
国家自然科学基金(81772639、81802475)
北京市自然科学基金(7192157)
中国医学科学院医学与健康创新工程重大协同创新项目(2016-I2M-1-001).
